首页> 外文期刊>Cell death and differentiation >A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells.
【24h】

A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells.

机译:p38alpha在大肠癌细胞中自噬和细胞死亡控制中的新型细胞类型特异性作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer develops when molecular pathways that control the fine balance between proliferation, differentiation, autophagy and cell death undergo genetic deregulation. The prospects for further substantial advances in the management of colorectal cancer reside in a systematic genetic and functional dissection of these pathways in tumor cells. In an effort to evaluate the impact of p38 signaling on colorectal cancer cell fate, we treated HT29, Caco2, Hct116, LS174T and SW480 cell lines with the inhibitor SB202190 specific for p38alpha/beta kinases. We report that p38alpha is required for colorectal cancer cell homeostasis as the inhibition of its kinase function by pharmacological blockade or genetic inactivation causes cell cycle arrest, autophagy and cell death in a cell type-specific manner. Deficiency of p38alpha activity induces a tissue-restricted upregulation of the GABARAP gene, an essential component of autophagic vacuoles and autophagosomes, whereas simultaneous inhibition of autophagy significantly increases cell death by triggering apoptosis. These data identify p38alpha as a central mediator of colorectal cancer cell homeostasis and establish a rationale for the evaluation of the pharmacological manipulation of the p38alpha pathway in the treatment of colorectal cancer.
机译:当控制增殖,分化,自噬和细胞死亡之间精细平衡的分子途径经历遗传失调时,就会发生癌症。结直肠癌治疗的进一步实质性进展的前景在于肿瘤细胞中这些途径的系统遗传和功能解剖。为了评估p38信号对结直肠癌细胞命运的影响,我们用对p38alpha /β激酶具有特异性的抑制剂SB202190处理了HT29,Caco2,Hct116,LS174T和SW480细胞系。我们报告说,p38alpha是结直肠癌细胞稳态所必需的,因为通过药理学封锁或遗传失活抑制其激酶功能会导致细胞周期停滞,自噬和细胞死亡,这是一种细胞类型特异性方式。 p38alpha活性不足会诱导GABARAP基因的组织限制上调,GABARAP基因是自噬泡和自噬小体的重要组成部分,而同时抑制自噬会通过触发凋亡显着增加细胞死亡。这些数据确定了p38alpha是结直肠癌细胞稳态的主要介质,并为评估p38alpha途径在结直肠癌治疗中的药理学操作建立了理论基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号